BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6430791)

  • 41. Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1983 Sep; 50(1):75-84. PubMed ID: 6193057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T; Circolo A
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():5-9. PubMed ID: 6587743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemolytic complement activity and humoral immune responses to sheep red blood cells in indigenous chickens and in eight German Dahlem Red chicken lines with different combinations of major genes (dwarf, naked neck and frizzled) of tropical interest.
    Baelmans R; Parmentier HK; Nieuwland MG; Dorny P; Demey F; Berkvens D
    Trop Anim Health Prod; 2005 Apr; 37(3):173-86. PubMed ID: 15747855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variations in sheep serum conglutinating complement activity and pathway involved in reactivity with sheep erythrocytes sensitized by rabbit antibody.
    Stankiewicz M; Jonas W
    Arch Immunol Ther Exp (Warsz); 1985; 33(3):423-8. PubMed ID: 3851656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K; Zbar B; Borsos T; Glenn G
    Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracts of wheat gluten activate complement via the alternative pathway.
    Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
    Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-independent activation of the classical pathway of complement by Epstein-Barr virus.
    Martin H; McConnell I; Gorick B; Hughes-Jones NC
    Clin Exp Immunol; 1987 Mar; 67(3):531-6. PubMed ID: 3038440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysis of C1Q-coated chicken erythrocytes by human lymphoblastoid cell lines.
    Ghebrehiwet B; Müller-Eberhard HJ
    J Immunol; 1978 Jan; 120(1):27-32. PubMed ID: 564373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
    Nelson B; Ruddy S
    J Immunol; 1979 May; 122(5):1994-9. PubMed ID: 376729
    [No Abstract]   [Full Text] [Related]  

  • 57. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody-independent activation of the alternative complement pathway in human serum by parasitic cells.
    Kierszenbaum F; Weinman D
    Immunology; 1977 Feb; 32(2):245-9. PubMed ID: 844897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human alternative complement pathway-mediated lysis of rabbit erythrocytes is enhanced by natural anti-Galalpha1-3Gal antibodies.
    Tomlinson S; Nussenzweig V
    J Immunol; 1997 Dec; 159(11):5606-9. PubMed ID: 9548503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis.
    Bakács T; Tótpál K; Ringwald G; Yefenof E
    J Clin Lab Immunol; 1988 Feb; 25(2):53-8. PubMed ID: 3373517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.